EVeRLAST 2-Year Follow-Up
2-Year Follow-Up: Expedited Versus Restrictive: Limitations on Activity Following Surgical Treatment of Prolapse (EVeRLAST)
1 other identifier
observational
63
1 country
1
Brief Summary
This is a 2-year follow-up study from EVeRLAST which objective was to determine whether expedited resumption of postoperative activity levels is non-inferior to standard activity restrictions with respect to short-term anatomic prolapse outcomes. The preliminary data from the original study suggest expedited instructions are non-inferior. We hypothesize this effect continues at the 2-year postoperative mark and patients continue to have non-inferior outcomes after prolapse surgery when compared to standard postoperative activity restrictions. Participants from the original EVeRLAST will be approached to assess their interest in participating in the 2-year follow up study. We will be collecting objective and subjective data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2022
CompletedFirst Posted
Study publicly available on registry
September 16, 2022
CompletedStudy Start
First participant enrolled
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2023
CompletedDecember 6, 2024
February 1, 2024
12 months
September 13, 2022
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Prolapse symptoms measured by the Pelvic Organ Prolapse Distress Inventory (POPDI)
The POPDI results in scores ranging from 0 to 300; higher scores indicate greater symptom distress.
2 year +/- 1 month following the initial prolapse surgery
Secondary Outcomes (6)
Functional activity measured by the Activities Assessment Scale (AAS)
2 year +/- 1 month following the initial prolapse surgery
Physical function assessed by the Global Impression of Improvement
2 year +/- 1 month following the initial prolapse surgery
Physical function assessed by the Patient Reported Outcomes Measurement Information System (PROMIS) Global Health Short Form
2 year +/- 1 month following the initial prolapse surgery
Pelvic floor symptom severity measured by the Pelvic Floor Distress Index (PFDI-20)
2 year +/- 1 month following the initial prolapse surgery
Physical function as measured by a 2-minute walk test (2MWT)
2 years +/- 1 month following the initial prolapse surgery
- +1 more secondary outcomes
Study Arms (2)
Expedited postoperative activity instructions
Ad lib postoperative activity and return to work recommendations
Standard postoperative activity restrictions
Standard conservative postoperative activity and return to work recommendations
Interventions
Ad lib postoperative activity and return to work recommendations
Standard conservative postoperative activity and return to work recommendations
Eligibility Criteria
Eligible subjects include all patients from the prior EVeRLAST study.
You may qualify if:
- Patient who were previously enrolled in the initial EVeRLAST study.
You may not qualify if:
- Enrollment in another research study of pelvic organ prolapse.
- Any patients who underwent further surgery in the 3 months following their prolapse surgery or patients who underwent unanticipated treatment which would result in prolonged inactivity (such as a cancer diagnosis) 3 months following their prolapse surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27707, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2022
First Posted
September 16, 2022
Study Start
September 30, 2022
Primary Completion
September 27, 2023
Study Completion
September 27, 2023
Last Updated
December 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share